Endocrinology Activities
Improving Outcomes in Diabetic Retinopathy: A Specialty Pharmacy Discussion of Outcomes and Cost- Effectiveness
0290-0000-18-145-H01-P
This program presented by PTCE will address the appropriate identification of risk factors for diabetic retinopathy, as well as diabetic macular edema (DME)
1.50
Emerging Strategies for the Safe and Effective Treatment of Uncontrolled Diabetes and the Availability of the Novel Fixed-Ratio Combination Insulin/GLP-1 RAs
0290-0000-18-116-L01-P
This activity highlights safety and efficacy data associated with GLP-1 RA and insulin fixed-ratio combination therapy and when to start patients on these agents to help control T2DM.
8-29-2018
1.00
An American Journal of Managed Care Medical Crossfire®: Management of Newer Ultra–Long–Acting Basal Insulin Agents in Diabetes
0290-0000-18-017-H01-P
This Medical Crossfire will highlight the safety and efficacy data related to the newer generation, ultra–long-acting insulins and their place in therapy.
2.00
Evaluating New–Generation Basal Insulin Therapy
0290-0000-18-022-H01-P
This supplement will provide managed care professionals with an overview of diabetes, the status of diabetes control in the U.S., and related comorbidities.
2.50